Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Neuromyelitis Optica × Mitoxantrone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Promyelocytic, Acute 2 Thyroid Cancer, Papillary 1 Neuromyelitis Optica 1 Myelitis, Transverse 1 Leukemia, Myeloid, Acute 1 Demyelinating Autoimmune Diseases, CNS 1 Autoimmune Diseases of the Nervous System 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00304291 2020-12-28

A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)

State University of New York at Buffalo

Phase 4 Completed

Myelitis, Transverse, Neuromyelitis Optica, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS

Data powered by HemOnc (CC BY 4.0) Colophon ⚡